Tigecycline Loading Dose: 100 mg IV
The FDA-approved and guideline-recommended loading dose for tigecycline is 100 mg IV, followed by 50 mg IV every 12 hours. This dosing regimen is consistently endorsed across multiple authoritative sources and represents the standard of care for adult patients 1.
Standard Adult Dosing
The loading dose of 100 mg IV is administered as the initial dose, followed by maintenance dosing of 50 mg IV every 12 hours 2, 1. This regimen applies to:
- Complicated intra-abdominal infections (cIAI): 5-14 days duration
- Complicated skin and skin structure infections (cSSSI): 5-14 days duration
- Community-acquired bacterial pneumonia (CABP): 7-14 days duration
Each infusion should be administered over 30-60 minutes 1.
Evidence Across Guidelines
Multiple international guidelines from 2022 consistently recommend this same loading dose:
- For carbapenem-resistant Enterobacterales (CRE) infections: 100 mg IV loading dose, then 50 mg IV q12h for complicated intra-abdominal infections 3
- For vancomycin-resistant enterococci (VRE): 100 mg IV loading dose, then 50 mg IV q12h for intra-abdominal infections 3
- For multidrug-resistant organisms: The same loading dose applies across various infection types 3
Higher Dosing Considerations
While the standard loading dose is 100 mg, some evidence suggests higher dosing may be beneficial in specific severe infections:
- For severe pneumonia/VAP: A 200 mg loading dose followed by 100 mg q12h has been studied and may achieve better outcomes, though this carries increased toxicity risk 4
- For bacteremia: Standard dosing achieves poor serum concentrations (Cmax <0.87 mg/L), making tigecycline generally unsuitable for bloodstream infections at approved doses 4
However, these higher doses are not FDA-approved and should only be considered in salvage situations with infectious disease consultation.
Special Populations
Severe hepatic impairment (Child-Pugh C): Use 100 mg loading dose, then reduce maintenance to 25 mg q12h 1
Pediatric patients (use only if no alternatives available):
- Ages 12-17 years: 50 mg q12h (no loading dose specified in most guidelines) 3, 1
- Ages 8-11 years: 1.2 mg/kg q12h (maximum 50 mg) 3, 1
Critical Limitations
- Avoid in bacteremia: Tigecycline achieves inadequate serum levels for bloodstream infections at standard dosing 4
- Inferior for complicated UTI: Multiple studies show tigecycline is inferior to aminoglycosides for urinary tract infections caused by CRE 5
- Not monotherapy for CRAB pneumonia: Strong recommendation against tigecycline monotherapy for carbapenem-resistant Acinetobacter baumannii pneumonia 3
- Increased mortality signal: FDA warnings note numerically higher mortality in tigecycline-treated patients compared to comparators in some trials 1
Administration Details
Reconstitute each 50 mg vial with 5.3 mL of 0.9% sodium chloride, 5% dextrose, or lactated Ringer's to achieve 10 mg/mL concentration. For the 100 mg loading dose, reconstitute two vials and dilute in 100 mL IV bag (maximum concentration 1 mg/mL) 1.